• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Glycylglutamine

Glycylglutamine

Product ID G6400
Cas No. 13115-71-4
Purity ≥95%
Product Unit SizeCostQuantityStock
5 mg $98.40 Please Inquire
10 mg $167.80 Please Inquire
25 mg $294.60 Please Inquire
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Glycylglutamine (GQ) is an endogenous β-endorphin-derived dipeptide that exhibits antioxidative, cardioprotective, anti-inflammatory, and neuromodulatory activities. In animal models of burn injury, GQ decreases serum creatine kinase, lactate dehydrogenase, and lactic acid and increases serum ATP and glutathione, decreasing myocardial damage and improving cardiac contractility. In animal models of liver transplant, GQ increases levels of secretory IgA (sIgA) and decreases levels of TNF-α, improving microvilli structure and intestinal barrier function. Additionally, GQ inhibits IL-1β-induced thermogenesis and prostaglandin E2 (PGE2) production, suppressing the development of fever in vivo. In animal models of opioid use, GQ inhibits opioid-induced dopamine signaling, preventing reward and suppressing development of tolerance and withdrawal. GQ also inhibits nicotine-induced reward signaling in conditioned place preference (CPP) paradigms as well as development of nicotine withdrawal.

Product Info

Cas No.

13115-71-4

Purity

≥95%

Formula

C7H13N3O4

Formula Wt.

203.2

IUPAC Name

(2S)-5-amino-2-[(2-aminoacetyl)amino]-5-oxopentanoic acid

Synonym

GQ

Solubility

Soluble in water, acid.

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

G6400 MSDS PDF

Info Sheet

G6400 Info Sheet PDF

References

Zhang Y, Yan H, Lv SG, et al. Effects of glycyl-glutamine dipeptide supplementation on myocardial damage and cardiac function in rats after severe burn injury. Int J Clin Exp Pathol. 2013 Apr 15;6(5):821-30. PMID: 23638213.

Jiang JW, Ren ZG, Chen LY, et al. Enteral supplementation with glycyl-glutamine improves intestinal barrier function after liver transplantation in rats. Hepatobiliary Pancreat Dis Int. 2011 Aug;10(4):380-5. PMID: 21813386.

Basaran NF, Buyukuysal RL, Millington WR, et al. Glycyl-glutamine (beta-endorphin(30-31)) inhibits morphine-induced dopamine efflux in the nucleus accumbens. Naunyn Schmiedebergs Arch Pharmacol. 2010 May;381(5):467-75. PMID: 20349045.

Göktalay G, Cavun S, Levendusky MC, et al. Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal. Eur J Pharmacol. 2006 Jan 13;530(1-2):95-102. PMID: 16364288.

Resch GE, Millington WR. Inhibition of interleukin-1beta and prostaglandin E(2) thermogenesis by glycyl-glutamine, a pro-opiomelanocortin-derived peptide. Brain Res. 2001 Mar 16;894(2):316-20. PMID: 11251208.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • T0008

    Tacrolimus

    Calcineurin inhibitor.

    ≥98%
  • E7657

    Etoposide

    Podophyllotoxin derivative; topoisomerase II in...

    ≥98%
  • A145823

    ADU-S100 sodium salt

    Synthetic cyclic dinucleotide agonist of STING....

    ≥99%
  • Z2268

    Z-FR-AMC

    Protease substrate.

    ≥95%
  • B8248

    Bumetanide

    Loop diuretic; NKCC symporter and KCC2 co-trans...

    ≥98%
  • D3420

    4-(3,4-Difluorobenzo)curcumin

    Curcumin derivative.

    ≥95%
  • O9458

    Oxolinic Acid

    Fluoroquinolone; bacterial DNA gyrase inhibitor...

    ≥98%
  • C179602

    CEP-28122

    ALK inhibitor.

    ≥98%
  • P7034

    Prion Peptide (106-126), human

    Synthetic peptide fragment, prion protein analo...

    ≥95%
  • C2970

    Chrysophanol

    Anthraquinone found in Rheum.

    ≥98%
  • B6802

    Bradykinin (1-3)

    Natriuretic, vasodilatory peptide fragment; B1/...

    ≥95%
  • A4926

    AMG-458

    c-MET inhibitor.

    ≥98%
  • P577520

    Ponatinib

    pan-Bcr-Abl tyrosine kinase inhibitor.

    ≥99%
  • T8000

    Tubacin

    HDAC6 inhibitor.

    ≥96%
  • G4434

    Gliotoxin

    Toxin produced by Aspergillus.

    ≥98%
  • E6996

    Erythromycin Thiocyanate

    Macrolide; protein translation inhibitor, mamma...

    ≥90%
  • T2834

    Thiolutin

    Dithiolopyrrolone; RNA polymerase inhibitor.

    ≥98%
  • N6076

    N(p-Tosyl)-GPR-pNA

    Thrombin substrate used to measure thrombin act...

    ≥95%
  • P005095

    N-Debenzoylpaclitaxel

    Paclitaxel derivative

    ≥95%
  • V5870

    Vortioxetine

    5-HT1A agonist, 5-HT1B partial agonist, 5-HT3A/...

    ≥99%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only